Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population reappraisal of the role of programmed ventricular stimulation

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 3, 2013, Pages 504-512

  Gatzoulis, Konstantinos A ^a   Vouliotis, Apostolos Ilias ^a   Tsiachris, Dimitris ^a   Salourou, Maria ^a   Archontakis, Stefanos ^a   Dilaveris, Polychronis ^a   Gialernios, Theodoros ^a   Arsenos, Petros ^a   Karystinos, Georgios ^a   Sideris, Skevos ^b   Kallikazaros, Ioannis ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Dilated cardiomyopathy; Electrophysiology test; Implantable cardioverter defibrillator; Primary prevention; Risk stratification

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR PROCEDURE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR PACEMAKER; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; POPULATION; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PROGRAMMED VENTRICULAR STIMULATION; SUDDEN CARDIAC DEATH; AGE; AGED; COHORT ANALYSIS; CONFIDENCE INTERVAL; ELECTROPHYSIOLOGY TEST; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK STRATIFICATION; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SURVIVAL; TREATMENT OUTCOME;

DILATED CARDIOMYOPATHY; ELECTROPHYSIOLOGY TEST; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; PRIMARY PREVENTION; RISK STRATIFICATION;

ADULT; AGE FACTORS; AGED; CARDIOMYOPATHY, DILATED; COHORT STUDIES; CONFIDENCE INTERVALS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84882939999     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000216     Document Type: Article

References (25)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2006;114:e385-484.
2. Grimm W, Glaveris C, Hoffmann J, Menz V, Müller HH, Hufnagel G, Maisch B. Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour holter electrocardiography. Am Heart J. 2000;140:43-51.
3. Grimm W, Christ M, Sharkova J, Maisch B. Arrhythmia risk prediction in idiopathic dilated cardiomyopathy based on heart rate variability and baroreflex sensitivity. Pacing Clin Electrophysiol. 2005;28 suppl 1:S202-S206.
4. Grimm W, Christ M, Bach J, Müller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation. 2003;108:2883-2891.
5. Hsia HH, Marchlinski FE. Electrophysiology studies in patients with dilated cardiomyopathies. Card Electrophysiol Rev. 2002;6:472-481.
6. Brembilla-Perrot B, Donetti J, de la Chaise AT, Sadoul N, Aliot E, Juillière Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J. 1991;121(4 pt 1):1124-1131.
7. Poll DS, Marchlinski FE, Buxton AE, Josephson ME. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol. 1986;58:992-997.
8. Das SK, Morady F, DiCarlo L Jr, Baerman J, Krol R, De Buitleir M, Crevey B. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol. 1986;58:998-1000.
9. Brilakis ES, Friedman PA, Maounis TN, Rokas SG, Shen WK, Stamatelopoulos SF, Cokkinos DV. Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter- defibrillators: a case series and a systematic review of the literature. Int J Cardiol. 2005;98:395-401.
10. Buxton AE, Marchlinski FE, Waxman HL, Flores BT, Cassidy DM, Josephson ME. Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol. 1984;53:1275-1279.
11. Gonska BD, Bethge KP, Kreuzer H. Programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy: influence of the underlying heart disease on the results of electrophysiologic testing. Clin Cardiol. 1987;10:294-304.
12. Constantin L, Martins JB, Kienzle MG, Brownstein SL, McCue ML, Hopson RC. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents. Pacing Clin Electrophysiol. 1989;12:776-783.
13. Chen X, Shenasa M, Borggrefe M, Block M, Hindricks G, Martinez-Rubio A, Haverkamp W, Willems S, Böcker D, Mäkijärvi M. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. Eur Heart J. 1994;15:76-82.
14. Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 2002;105:1453-1458.
15. Manolis AS, Vardas P, Sakantamis G, Gatzoulis K, Manolis AG. Guidelines for the implantation of cardiac defibrillators. Hellenic J Cardiol. 1996;37:165-171.
16. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation. 2006;113:776-782.
17. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT study. Eur Heart J. 2009;30:2758-2767.
18. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM; EMPIRIC Trial Investigators. A comparison of empiric to physiciantailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006;48:330-339.
19. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, for the PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients results from the PREPARE Study. J Am Coll Cardiol. 2008;52:541-550.
20. Russo AM, Verdino R, Schorr C, Nicholas M, Dias D, Hsia H, Callans D, Marchlinski FE. Occurrence of implantable defibrillator events in patients with syncope and nonischemic dilated cardiomyopathy. Am J Cardiol. 2001;88:1444-1446, A9.
21. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of lowvoltage scars. J Am Coll Cardiol. 2004;43:1834-1842.
22. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
23. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
24. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
25. Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis. Europace. 2009;11:289-296.